Sponsor:
Ohio State University Comprehensive Cancer Center
Code:
NCT06089408
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Best Practice
Supportive Care
Survey Administration
Brief summary:
Conditions
Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm
Study ID
NCT06089408
Start date
Aug 1, 2023
Status verified date
Aug, 2026
Completion date
Dec 31, 2027
Anticipated
Primary completion date
Jun 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
114 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Arm I (weighted blanket)
active comparator: Arm II (regular blanket)
Interventions
Best Practice
Supportive Care
Survey Administration
Primary outcome measure
Central contacts
Locations
Ohio State University Comprehensive Cancer Center
Recruiting
Columbus, Ohio, United States, 43210
Contacts
Principal Investigator:
Allison De Villiers, MSN, RN, ONC
Sponsor
Ohio State University Comprehensive Cancer Center
Last update posted
Aug 5, 2026
Last verified
Aug, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Ohio State University Comprehensive Cancer Center on 2026-08-05.